Published in Nucleic Acids Res on May 11, 1994
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J (1995) 2.48
Replication stress induces 53BP1-containing OPT domains in G1 cells. J Cell Biol (2011) 2.18
Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol (1998) 2.03
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol (2005) 1.55
The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc. Mol Cell Biol (1996) 1.26
CCAAT binding NF-Y-TBP interactions: NF-YB and NF-YC require short domains adjacent to their histone fold motifs for association with TBP basic residues. Nucleic Acids Res (1997) 1.24
Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1. Nucleic Acids Res (1996) 1.13
The ability to associate with activation domains in vitro is not required for the TATA box-binding protein to support activated transcription in vivo. Proc Natl Acad Sci U S A (1995) 1.09
Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cyclic AMP signalling pathway. Mol Cell Biol (1995) 0.98
Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription. EMBO J (1997) 0.98
Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism. Mol Cell Biol (2002) 0.98
Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1. Nucleic Acids Res (1996) 0.96
Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res (1994) 0.89
Identification of a POU factor involved in regulating the neuron-specific expression of the gene encoding diapause hormone and pheromone biosynthesis-activating neuropeptide in Bombyx mori. Biochem J (2004) 0.89
Octamer-binding transcription factors: genomics and functions. Front Biosci (Landmark Ed) (2013) 0.88
Anti-inflammatory cytokine interleukin-4 inhibits inducible nitric oxide synthase gene expression in the mouse macrophage cell line RAW264.7 through the repression of octamer-dependent transcription. Mediators Inflamm (2013) 0.87
Involvement of the ubiquitous Oct-1 transcription factor in hormonal induction of beta-casein gene expression. Biochem J (2007) 0.86
Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter. Mol Immunol (2012) 0.84
Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site. Nucleic Acids Res (1997) 0.81
Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells. Mol Cell Biol (1998) 0.79
BET proteins are a key component of immunoglobulin gene expression. Epigenomics (2017) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science (1989) 25.68
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (1986) 14.34
Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell (1985) 13.36
Five intermediate complexes in transcription initiation by RNA polymerase II. Cell (1989) 9.22
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell (1990) 8.11
Transcriptional selectivity of viral genes in mammalian cells. Cell (1986) 7.95
Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. Proc Natl Acad Sci U S A (1984) 7.74
Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature (1984) 7.66
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev (1988) 6.23
Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc Natl Acad Sci U S A (1992) 6.23
Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell (1991) 6.04
The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature (1989) 5.43
A cloned octamer transcription factor stimulates transcription from lymphoid-specific promoters in non-B cells. Nature (1988) 5.16
Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter. Genes Dev (1992) 4.85
Binding of general transcription factor TFIIB to an acidic activating region. Nature (1991) 4.71
Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell (1991) 4.66
A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J (1989) 4.47
Transcription factor ATF interacts with the TATA factor to facilitate establishment of a preinitiation complex. Cell (1988) 4.15
An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (1987) 4.11
Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci U S A (1992) 4.06
Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature (1991) 3.98
Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J (1988) 3.33
The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev (1991) 3.24
Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science (1992) 3.13
Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science (1988) 3.01
Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell (1992) 2.97
Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. Proc Natl Acad Sci U S A (1991) 2.95
The POU domain is a bipartite DNA-binding structure. Nature (1988) 2.92
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A (1993) 2.90
Advances in RNA polymerase II transcription. Curr Opin Cell Biol (1992) 2.81
Distinct TFIID complexes mediate the effect of different transcriptional activators. EMBO J (1993) 2.66
Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Genes Dev (1988) 2.38
The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol Cell Biol (1993) 2.37
The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J (1992) 2.36
Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (1993) 2.28
Transcriptional regulation by the immediate early protein of pseudorabies virus during in vitro nucleosome assembly. Cell (1988) 2.23
A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes Dev (1992) 2.23
Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J Biol Chem (1993) 2.15
The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription. EMBO J (1990) 2.01
An upstream transcription factor, USF (MLTF), facilitates the formation of preinitiation complexes during in vitro chromatin assembly. EMBO J (1990) 1.99
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B. Nature (1993) 1.94
Dominant negative mutations in yeast TFIID define a bipartite DNA-binding region. Cell (1991) 1.91
The Oct-2 protein binds cooperatively to adjacent octamer sites. Genes Dev (1989) 1.91
Recognition of the surface of a homeo domain protein. Genes Dev (1992) 1.85
POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter. Genes Dev (1991) 1.84
How do different transcription factors binding the same DNA sequence sort out their jobs? Trends Genet (1989) 1.83
Functional differences between yeast and human TFIID are localized to the highly conserved region. Cell (1991) 1.80
Factors (TAFs) required for activated transcription interact with TATA box-binding protein conserved core domain. Genes Dev (1993) 1.74
Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol Cell Biol (1993) 1.70
Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res (1991) 1.65
Cooperativity in transactivation between retinoic acid receptor and TFIID requires an activity analogous to E1A. Cell (1992) 1.50
p53 binds to the TATA-binding protein-TATA complex. J Biol Chem (1993) 1.42
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol Cell Biol (1992) 1.35
A bipartite DNA binding domain composed of direct repeats in the TATA box binding factor TFIID. Proc Natl Acad Sci U S A (1992) 1.29
Oct-2 facilitates functional preinitiation complex assembly and is continuously required at the promoter for multiple rounds of transcription. EMBO J (1993) 1.05
A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence. Nucleic Acids Res (1991) 1.01
Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. J Biol Chem (1993) 0.90
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature (1987) 4.11
NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med (1999) 2.96
High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors. EMBO J (1995) 2.48
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Distinct NF-kappa B/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature (1993) 2.28
A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet (1996) 2.16
Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells. Science (1997) 1.93
Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem (2001) 1.92
Multiple Oct2 isoforms are generated by alternative splicing. Nucleic Acids Res (1991) 1.65
Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology (2000) 1.56
Family of middle repetitive DNA sequences in the mouse genome with structural features of solitary retroviral long terminal repeats. Proc Natl Acad Sci U S A (1983) 1.54
[Colonic stenting: an opportunity with a risk : A critical evaluation]. Chirurg (2015) 1.38
Raf induces NF-kappaB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation. Proc Natl Acad Sci U S A (2000) 1.36
Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity. Mol Cell Biol (1992) 1.35
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut (2005) 1.34
Structure and genomic organization of a new family of murine retrovirus-related DNA sequences (MuRRS). Nucleic Acids Res (1985) 1.33
Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J (1994) 1.30
Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1. J Biol Chem (1999) 1.27
Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood (1998) 1.25
Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc Natl Acad Sci U S A (2001) 1.24
Regulation of BOB.1/OBF.1 stability by SIAH. EMBO J (2001) 1.23
Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol (1993) 1.19
Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1. J Biol Chem (1995) 1.10
Identification of CD36 as the first gene dependent on the B-cell differentiation factor Oct-2. Genes Dev (1995) 1.06
Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin Cancer Res (2001) 1.05
Evidence for mobility of a new family of mouse middle repetitive DNA elements (LTR-IS). Nucleic Acids Res (1984) 1.03
Early age of onset in fatal familial insomnia. Two novel cases and review of the literature. J Neurol (2004) 1.02
Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors. Oncogene (1995) 1.02
Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01
A strategy for efficient in vitro translation of cDNAs using the rabbit beta-globin leader sequence. Nucleic Acids Res (1991) 1.01
Mitochondrial differentiation in a polymorphic land snail: evidence for Pleistocene survival within the boundaries of permafrost. J Evol Biol (2003) 1.01
CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J Immunol (1996) 1.01
Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther (2006) 1.00
Model for estimating enteric methane emissions from United States dairy and feedlot cattle. J Anim Sci (2008) 1.00
Failures and complications in intramedullary nailing of children's forearm fractures. J Child Orthop (2010) 0.99
The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development. Mol Cell Biol (2001) 0.98
Treatment of severely displaced proximal humeral fractures in children with retrograde elastic stable intramedullary nailing. Injury (2008) 0.98
Evidence that a major class of mouse endogenous long terminal repeats (LTRs) resulted from recombination between exogenous retroviral LTRs and similar LTR-like elements (LTR-IS). Proc Natl Acad Sci U S A (1984) 0.97
Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther (2003) 0.96
NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival. Cytokine Growth Factor Rev (2000) 0.96
The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells. Eur J Immunol (2000) 0.96
[Treatment of congenital clubfoot with the Ponseti method]. Z Orthop Ihre Grenzgeb (2006) 0.95
Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities. EMBO J (1994) 0.95
CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol Cell Biol (1996) 0.93
Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol (2008) 0.92
Novel twelve-generation kindred of fatal familial insomnia from germany representing the entire spectrum of disease expression. Am J Med Genet (1999) 0.92
Bruton's Tyrosine Kinase is involved in innate and adaptive immunity. Histol Histopathol (2005) 0.91
Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. J Biol Chem (1993) 0.90
Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res (1994) 0.89
Magnetic resonance imaging of viral particle biodistribution in vivo. Gene Ther (2006) 0.89
Induction of nuclear factor-kappa B during primary B cell differentiation. J Immunol (1998) 0.87
Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice. Nucleic Acids Res (1992) 0.86
Isolation and characterization of microsatellite loci in the yellow perch (Perca flavescens), and cross- species amplification within the family Percidae. Mol Ecol (2000) 0.85
Requirement of NEMO/IKKγ for effective expansion of KRAS-induced precancerous lesions in the pancreas. Oncogene (2012) 0.85
VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1. Gene Ther (2009) 0.84
Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. Blood (2001) 0.83
Arthroscopic reduction of the dislocated hip in infants. J Bone Joint Surg Br (2012) 0.83
[Treatment of vertical talus with the Dobbs method]. Z Orthop Unfall (2011) 0.83
[Wound secretions in standard orthopedic surgery interventions using a new kind of closed vacuum drainage. A report of experiences]. Unfallchirurg (1991) 0.82
Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Nucleic Acids Res (1991) 0.82
The zinc-finger protein KCMF1 is overexpressed during pancreatic cancer development and downregulation of KCMF1 inhibits pancreatic cancer development in mice. Oncogene (2010) 0.81
Molecular principles of Oct2-mediated gene activation in B cells. Immunobiology (1995) 0.80
No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats. Eur J Pharmacol (1998) 0.80
Glutamate-dependent activation of NF-kappaB during mouse cerebellum development. J Neurosci (1997) 0.80
The influence of intermittent external dynamic pressure and tension forces on the healing of an epiphyseal fracture. Arch Orthop Trauma Surg (2001) 0.80
Targeting of biotinylated compounds to its target tissue using a low-density lipoprotein receptor-avidin fusion protein. Gene Ther (2003) 0.80
Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy. Cancer Gene Ther (2012) 0.80
RelB is a key player for both kappa B-dependent transcription and demethylation in B cells. Immunobiology (1997) 0.79
Assessment of the treatment costs of extracorporeal shock wave therapy versus surgical treatment for shoulder diseases. Int J Technol Assess Health Care (2001) 0.79
[Diagnosis and therapy of coxitis fugax with special reference to the value of ultrasonographY-assisted diagnosis and hip joint puncture]. Z Orthop Ihre Grenzgeb (1993) 0.79
Novel polymer-bound chiral selenium electrophiles. Org Lett (2001) 0.79
Demethylation and the establishment of kappa allelic exclusion. Cold Spring Harb Symp Quant Biol (1999) 0.79
Identification of target genes of the lymphoid-specific transcription factor Oct2. Immunobiology (1997) 0.79
[Mid-term results of idiopathic clubfeet treated with the Ponseti method]. Z Orthop Unfall (2012) 0.79
Genetic signatures in an invasive parasite of Anguilla anguilla correlate with differential stock management. J Fish Biol (2010) 0.78
In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system. Cancer Gene Ther (1999) 0.78
[Predicting the outcome of diskectomy.]. Schmerz (1991) 0.78
Molecular genetics of the germinal center reaction. J Cell Physiol (1998) 0.78
The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kappaB activation. J Biol Chem (1998) 0.77
ABF-1 is frequently silenced by promoter methylation in follicular lymphoma, diffuse large B-cell lymphoma and Burkitt's lymphoma. Leukemia (2008) 0.77
Analysis of promoter activity by polymerase chain reaction amplification of reporter gene mRNA. Anal Biochem (1996) 0.77
Isolation and characterization of 12 dinucleotide microsatellites in the European eel, Anguilla anguilla L., and tests of amplification in other species of eels. Mol Ecol Resour (2008) 0.77
Coordinate suppression of myeloma-specific genes and expression of fibroblast-specific genes in myeloma X fibroblast somatic cell hybrids. Somat Cell Mol Genet (1996) 0.76
[Minimally invasive treatment of congenital foot deformities in infants: new findings and midterm-results]. Orthopade (2013) 0.76
[Is conservative treatment of partial or complete anterior cruciate ligament rupture still justified? An analysis of the recent literature and a recommendation for arriving at a decision]. Z Orthop Ihre Grenzgeb (1992) 0.76
[Elastic stable intramedullary nailing as alternative therapy for the management of paediatric humeral shaft fractures]. Z Orthop Unfall (2009) 0.76
Controversies in childhood osteosarcoma. Minerva Pediatr (2013) 0.76
Clinical significance of apoptotic index in non-small cell lung cancer: correlation with p53, mdm2, pRb and p21WAF1/CIP1 protein expression. J Cancer Res Clin Oncol (2005) 0.76
False-positive sonographic hip examinations in newborns with congenital varus deformity of the proximal femur. Arch Orthop Trauma Surg (1995) 0.75
[Coxitis fugax--the beginning of Perthes' disease?]. Z Orthop Ihre Grenzgeb (2006) 0.75
[The effect of asbestos cement, UICC asbestos samples and quartz on the peritoneum of the mouse]. Pathol Microbiol (Basel) (1975) 0.75
[Alpha-1-antitrypsin in the cord blood]. Gynakol Rundsch (1980) 0.75
[Comparison of the diagnostic value of X-ray versus MRI in paediatric spine injuries]. Z Orthop Unfall (2011) 0.75
ICPD perspectives: institutional views. U.S., other countries increase efforts. Netw Res Triangle Park N C (1995) 0.75
Comprehensive comparison of various techniques for the analysis of elemental distributions in thin films. Microsc Microanal (2011) 0.75